AXL - AXL receptor tyrosine kinase Gene

Species: Canis lupus familiaris (sub-species: familiaris)

Gene Type: protein coding
Gene ID: 484490

AXL Products (4)

mRNA Protein Name
XM_038656903.1 XP_038512831.1 tyrosine-protein kinase receptor UFO isoform X4
XM_038656902.1 XP_038512830.1 tyrosine-protein kinase receptor UFO isoform X3
XM_038656901.1 XP_038512829.1 tyrosine-protein kinase receptor UFO isoform X2
XM_038656900.1 XP_038512828.1 tyrosine-protein kinase receptor UFO isoform X1
Protein Preferred Names Protein Names

tyrosine-protein kinase receptor UFO

LOW QUALITY PROTEIN: tyrosine-protein kinase receptor UFO

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-13016 Cabozantinib Inhibitor 99.97% Yes
HY-12432 Gilteritinib Inhibitor 99.84% Yes
HY-12432A Gilteritinib hemifumarate Inhibitor 99.75% Yes
HY-13016A Cabozantinib hydrochloride Inhibitor / Unkown

Clinical Phase

Bioactive Molecules (10)
Cat. No. Product Name Effect
Purity Phase
HY-138696 Zanzalintinib Inhibitor 99.91% Phase 3
HY-15150 Bemcentinib Inhibitor 99.92% Phase 2
HY-12076 BMS 777607 Inhibitor 99.36% Phase 2
HY-12963 Dubermatinib Inhibitor 99.84% Phase 2
HY-114358 Tamnorzatinib Inhibitor 98.59% Phase 2
HY-107145A Ningetinib Inhibitor 99.63% Phase 2
HY-107145 Ningetinib Tosylate Inhibitor 99.59% Phase 2
HY-152830A Adrixetinib TFA Inhibitor 99.82% Phase 2
HY-100946 CEP-40783 Inhibitor 99.61% Phase 1
HY-147218 PF-07265807 Inhibitor 95.18% Phase 1
Inhibitory Antibodies (4)
Cat. No. Product Name Effect
Purity Phase
HY-P99463 Batiraxcept 99.91% Phase 3
HY-P99360 Enapotamab Inhibitor 99.9% Phase 2
HY-P99161 Tilvestamab Inhibitor 98.08% Phase 1
HY-P991664 AG01 Inhibitor 95.10% Phase 1

Pre-clinical Phase

Bioactive Molecules (46)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-114166 2-D08 Inhibitor 99.37% Unkown
HY-15797 UNC2250 Inhibitor 99.92% Unkown
HY-12494 LDC1267 Inhibitor 99.64% Unkown
HY-117596 UNC569 Inhibitor 99.92% Unkown
HY-132200 UNC5293 Inhibitor 99.93% Unkown
HY-12964 SGI-7079 Inhibitor 99.32% Unkown
HY-100509 NPS-1034 Inhibitor 98.0% Unkown
HY-117548 UNC1062 Inhibitor 98.92% Unkown
HY-173268 UNC9426 Inhibitor 99.51% Unkown
HY-124066 RU-302 Inhibitor 98.72% Unkown
HY-15798 UNC2881 Inhibitor 99.79% Unkown
HY-124502 UNC4203 Inhibitor 99.80% Unkown
HY-152830 Adrixetinib Inhibitor 99.55% Unkown
HY-114357A DS-1205b free base Inhibitor 99.92% Unkown
HY-132893 AZ14145845 Inhibitor 98.00% Unkown
HY-144627 PROTAC Axl Degrader 2 Inhibitor 98.01% Unkown
HY-13016S Cabozantinib-d6 Inhibitor 98.14% Unkown
HY-151904 AXL-IN-13 Inhibitor 98.03% Unkown
HY-150041 TL4830031 Inhibitor ≥98.0% Unkown
HY-146615 Axl-IN-6 Inhibitor / Unkown
HY-152075 AXL-IN-14 Inhibitor / Unkown
HY-147574 Axl-IN-7 Inhibitor / Unkown
HY-147575 Axl-IN-8 Inhibitor / Unkown
HY-144708 Axl-IN-4 Inhibitor / Unkown
HY-144624 PROTAC Axl Degrader 1 Inhibitor / Unkown
HY-115778 UNC3133 Inhibitor / Unkown
HY-176204 Axl-IN-19 Inhibitor / Unkown
HY-147578 Axl-IN-11 Inhibitor / Unkown
HY-183774 NTQ2494 Inhibitor / Unkown
HY-153012 Axl/Mer/CSF1R-IN-1 Inhibitor / Unkown
HY-147576 Axl-IN-9 Inhibitor / Unkown
HY-15150G Bemcentinib (GMP) Inhibitor / Unkown
HY-184184 Axl ligand-1 Ligand / Unkown
HY-173400 UNC8212 Inhibitor / Unkown
HY-104075 R916562 Inhibitor / Unkown
HY-153441 AXL-IN-15 Inhibitor / Unkown
HY-147577 Axl-IN-10 Inhibitor / Unkown
HY-149092 Anticancer agent 109 / Unkown
HY-144706 Axl-IN-3 Inhibitor / Unkown
HY-147579 Axl-IN-12 Inhibitor / Unkown
HY-162085 Axl-IN-17 Inhibitor / Unkown
HY-122601 TAM-IN-1 Inhibitor / Unkown
HY-N12041 Axl-IN-16 Inhibitor / Unkown
HY-179535 Axl-IN-21 Inhibitor / Unkown
HY-146596 Axl-IN-5 Inhibitor / Unkown
HY-149491 HIV-IN-7 Inhibitor / Unkown
Inhibitory Antibodies (3)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P9988 Mecbotamab Inhibitor 99.83% Unkown
HY-P99733 Mipasetamab Inhibitor 98.26% Unkown
HY-P992116 Ladarutatug Inhibitor 95.40% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens AXL NCBI NCBI:558